Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.
NCT ID: NCT04886245
Last Updated: 2023-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-05-06
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed palliative treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. In this context, patients' expectations and feelings about their care may become difficult for clinicians to apprehend.
The eye-tracking is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular. Published studies focus on the gaze of photographs, excluding any notion of dynamics and by the analysis of the gaze of outside observers, ignoring the patient's gaze.The main objective is to evaluate the attention paid to the facial side with abnormal facial movement by patients with facial paralysis compared to healthy volunteers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Ocular Torsion in Patients Suffering From Palsy of the Superior Rectus Extraocular Muscle
NCT02900885
Effects of Ocular Electroacupuncture on Trochlear Nerve Palsy
NCT03099473
Effects of Ocular Electroacupuncture on Oculomotor Nerve Palsy
NCT03099447
Ameliorating Stroke-induced Hemianopia Via Multisensory Training
NCT05894434
Right-front Direction in Parabolic Flight
NCT02517138
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
facial palsy
Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated
Video sequences
videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound \[o\], the labial protrusion on the sound \[pu\] and the wide smile uncovering the teeth.
Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.
healthy volunteers
\- Subject without major facial sequelae
Video sequences
videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound \[o\], the labial protrusion on the sound \[pu\] and the wide smile uncovering the teeth.
Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video sequences
videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound \[o\], the labial protrusion on the sound \[pu\] and the wide smile uncovering the teeth.
Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with peripheral facial palsy, irrespective of grade, whether or not previously treated
* Patient providing written informed consent
* Patient aged ≥ 18 years
* Patient affiliated to a social security system
* for Healthy voluntary subject :
* Subject without major facial sequelae
* Subject who provided written informed consent
* Major subject ≥ 18 years old
* Subject affiliated to a social security system
Exclusion Criteria
* Patient with recent peripheral facial palsy whose total recovery is possible
* Patient unable to provide written informed consent
* Patient with difficulties to follow instructions and especially to stand in front of a computer screen
* Minor patient \<18 years
* Patient under guardianship or curators or judicial safeguard
* for Healthy voluntary subject :
* Subject with major facial sequelae
* Subject not able to provide written informed consent
* Subject presenting difficulties in following instructions and in particular in standing still in front of a computer screen
* Minor subject \< 18 years old
* Subject under guardianship or curators or judicial safeguard
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2019_843_0089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.